# Bioaraba Health Research Institute: Not applicable (device, behavioral) study completed, 390 enrolled (Alcoholic Hepatitis)

**Score:** 40/100

| Field | Value |
|---|---|
| Sponsor | Bioaraba Health Research Institute |
| Sponsor type | Research network |
| Study | Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32) |
| NCT ID | NCT05294744 |
| Phase | Not applicable (device, behavioral) |
| Status | completed |
| Conditions | Alcoholic Hepatitis |
| Intervention types | drug |
| Target enrollment | 390 |
| Site countries | Spain |
| Posted | 2022-03-24 |
| Planned start | 2022-10-07 |
| Event | Completed |
| Event date | 2026-10-01 |
| Last update posted | 2026-10-16 |

## Why this score
- Completed: closeout, analysis and the next study ahead.
- 390 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT05294744). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.